Scientists develop protein to track brain's faint chemical signals

Researchers have engineered a protein that detects subtle glutamate signals between neurons, unveiling a previously hidden aspect of brain communication. This tool allows real-time observation of how brain cells process incoming information, potentially advancing studies on learning, memory, and neurological disorders. The findings, published in Nature Methods, highlight a breakthrough in neuroscience.

The brain's neurons communicate through electrical and chemical signals, but until now, scientists could only observe the outgoing electrical messages, leaving incoming chemical exchanges largely invisible. A new protein sensor, iGluSnFR4—pronounced 'glue sniffer'—changes that by capturing faint glutamate releases at synapses in real time. Glutamate, the brain's primary excitatory neurotransmitter, is crucial for processes like learning and memory, yet its brief, weak signals have been hard to measure.

Engineered by teams at the Allen Institute and HHMI's Janelia Research Campus, iGluSnFR4 acts as a molecular indicator sensitive enough to detect even the smallest synaptic events. This enables researchers to see how individual neurons integrate thousands of inputs before deciding to fire, shedding light on complex brain computations underlying thoughts and decisions.

"It's like reading a book with all the words scrambled and not understanding the order of the words or how they're arranged," explained Kaspar Podgorski, a lead author and senior scientist at the Allen Institute. "What we have invented here is a way of measuring information that comes into neurons from different sources, and that's been a critical part missing from neuroscience research."

The tool also holds promise for disease research. Disruptions in glutamate signaling are implicated in conditions including Alzheimer's disease, schizophrenia, autism, and epilepsy. By precisely monitoring these signals, scientists can better understand disease mechanisms and test potential therapies.

Collaboration was key to the sensor's success. "The success of iGluSnFR4 stems from our close collaboration started at HHMI's Janelia Research Campus between the GENIE Project team and Kaspar's lab," said Jeremy Hasseman, a scientist at Janelia. The protein is now available to researchers via Addgene, fostering wider use in neuroscience.

This advance bridges a gap in observing full neural conversations, moving beyond fragmented views to comprehensive insights into brain function.

Related Articles

Realistic depiction of GluD2 glutamate receptor activating as an ion channel via D-serine and GABA, with Johns Hopkins neuroscientists in a lab setting.
Image generated by AI

Johns Hopkins team finds delta-type glutamate receptors function as ligand-gated ion channels

Reported by AI Image generated by AI Fact checked

Johns Hopkins Medicine researchers report that delta-type ionotropic glutamate receptors (GluDs)—long debated as to whether they conduct ions—can act as ligand-gated ion channels. The Nature study used cryo-electron microscopy and membrane recording experiments to characterize human GluD2 and found it can be activated by the neurotransmitters D-serine and GABA, findings the authors say could help guide drug development for disorders linked to GluD mutations.

Researchers have uncovered how amyloid beta and inflammation may both trigger synapse pruning in Alzheimer's disease through a common receptor, potentially offering new treatment avenues. The findings challenge the notion that neurons are passive in this process, showing they actively erase their own connections. Led by Stanford's Carla Shatz, the study suggests targeting this receptor could preserve memory more effectively than current amyloid-focused drugs.

Reported by AI

Scientists at Brown University have identified a subtle brain activity pattern that can forecast Alzheimer's disease in people with mild cognitive impairment up to two and a half years in advance. Using magnetoencephalography and a custom analysis tool, the researchers detected changes in neuronal electrical signals linked to memory processing. This noninvasive approach offers a potential new biomarker for early detection.

Researchers at Nagoya University in Japan have developed miniature brain models using stem cells to study interactions between the thalamus and cortex. Their work reveals the thalamus's key role in maturing cortical neural networks. The findings could advance research into neurological disorders like autism.

Reported by AI Fact checked

Scientists at The Ohio State University have charted how patterns of brain wiring can predict activity linked to many mental functions across the entire brain. Each region shows a distinct “connectivity fingerprint” tied to roles such as language and memory. The peer‑reviewed findings in Network Neuroscience offer a baseline for studying healthy young adult brains and for comparisons with neurological or psychiatric conditions.

Researchers have demonstrated that restoring levels of a key brain energy molecule can reverse advanced Alzheimer's disease in mouse models, repairing damage and restoring cognitive function. The study, published on December 22, challenges the long-held view that the condition is irreversible. Findings from human brain tissue support the approach's potential relevance to patients.

Reported by AI

Scientists at Northwestern University have identified a toxic subtype of amyloid beta oligomers that triggers early Alzheimer's changes in the brain. Their experimental drug, NU-9, reduced this damage and inflammation in pre-symptomatic mice, suggesting potential for preventing the disease before symptoms appear. The findings highlight a new strategy for early intervention.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline